Brigatinib from Japan
Brigatinib is an ALK inhibitor for lung cancer treatment. This macrocyclic aromatic nitrogen-heterocycle drug substance imports under HTS 2933.99.75.00.
Duty Rate — Japan → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• GMP compliance audit trail required from API manufacturer
• Residual solvent analysis per ICH Q3C mandatory for entry
• Avoid declaring as 'new chemical entity' after FDA approval